Related Experiment Video
Updated: Dec 7, 2025
10:42
Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
17.6K
[Nutrition and microbiota in pediatric population. Health implications].
Ana Isabel Jiménez Ortega1, Rosa María Martínez García2, Marta Velasco Rodríguez-Belvis3
1Unidad de Gastroenterología Pediátrica. Hospital San Rafael.
Nutricion Hospitalaria
|September 30, 2020
Summary
This review explores the scientific evidence for probiotic efficacy in various health conditions. It aims to clarify which probiotic applications are supported by research and clinical guidelines for restoring gut microbiota balance.
Area of Science:
- Microbiology
- Gastroenterology
- Immunology
Background:
- The human body hosts a complex microbiota crucial for health.
- Microbiota dysbiosis is linked to various diseases.
- Probiotics are explored as a method to modulate microbiota and restore balance.
Purpose of the Study:
- To review and summarize evidence-based indications for probiotic use.
- To identify probiotic applications supported by scientific guides and studies.
- To provide clarity on the effectiveness of different probiotics for specific conditions.
Main Methods:
- Literature review of scientific studies.
- Analysis of clinical guidelines on probiotic use.
- Synthesis of evidence for various probiotic applications.
Main Results:
- Evidence varies significantly across different probiotic strains and indications.
- Specific probiotic uses are supported by robust scientific data.
- Not all marketed probiotics are effective for all claimed health benefits.
Conclusions:
- Probiotic efficacy is strain-specific and indication-dependent.
- Informed selection of probiotics based on evidence is crucial for therapeutic success.
- Further research is needed to fully elucidate probiotic mechanisms and applications.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
144
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
144
01:23Anatomy of the Intestines
86.0K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.0K
01:28Fungal Phylum Microsporidia
303
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
303
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
165
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
165
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
531
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
531
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
108
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108